Jo-ting N. Tsai - Publications

Redox-driven FABP1/PPARγ signaling fuels peroxisomal fatty acid oxidation and confers cetuximab resistance in drug-tolerant head and neck cancer cells.

Journal: Free radical biology & medicine

Published: November 04, 2025

Baseline salivary IL-6 as a predictive biomarker for complementary therapy response in radiation-induced oral mucositis.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: October 25, 2025

Association between daily vital signs during radiotherapy and severe infection in cancer patients: A case-control study.

Journal: Medicine

Published: October 06, 2025

Reducing low-dose exposure in helical TomoTherapy for locally advanced left-sided breast cancer with a deformable image registration-based dose-mimicking workflow.

Journal: Journal of applied clinical medical physics

Published: September 08, 2025

RHOJ-induced chemotherapy resistance through epithelial-mesenchymal transition in drug-tolerant persister cells of head and neck cancer.

Journal: Translational oncology

Published: August 28, 2025

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities.

Journal: Translational oncology

Published: August 17, 2025

Correction: Lee et al. Tumor-Associated Macrophages Affect the Tumor Microenvironment and Radioresistance via the Upregulation of CXCL6/CXCR2 in Hepatocellular Carcinoma. Biomedicines 2023, 11, 2081.

Journal: Biomedicines

Published: July 22, 2025

Effects of honey and Taiwanese green propolis on oral mucositis and quality of life in head and neck cancer patients undergoing radiotherapy: a randomized controlled trial.

Journal: Food & function

Published: May 27, 2025

Risk factors for early-onset radiodermatitis in patients with locally advanced breast cancer: a comparative analysis of volumetric modulated arc therapy and intensity-modulated radiotherapy.

Journal: Breast cancer (Tokyo, Japan)

Published: May 15, 2025

Targeting FABP4/UCP2 axis to overcome cetuximab resistance in obesity-driven CRC with drug-tolerant persister cells.

Journal: Translational oncology

Published: August 18, 2024

Vascular compactness of unruptured brain arteriovenous malformation predicts risk of hemorrhage after stereotactic radiosurgery.

Journal: Scientific reports

Published: November 13, 2023

Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.

Journal: Journal of clinical medicine

Published: October 05, 2023